The new plant, which will be online in 2013, joins Dow’s ultrafiltration manufacturing facility in Huzhou, ion exchange resin production unit in Qingpu and research centre in Shanghai.
“This investment is directly aligned to our growth strategy to maximise value as a leading science company, benefiting our customers in China and the China economy while contributing to Dow’s global growth,” said Peter Sykes, president of Dow Greater China.
“Reverse osmosis investment in China is an integral part of the DW&PS business growth strategy and by following this strategy we consistently enhance our capability. By expanding our manufacturing capacity we are improving our global footprint and strengthening our market position while simultaneously enhancing our global capabilities and competitiveness,” said Ian Barbour, general manager, Dow Water & Process Solutions.